口腔科

订阅

MedSci主页 / 所有栏目 / 口腔科

J Periodontol：钛和氧化锆植体表面生物膜的形成对比

2019-01-02 MedSci MedSci原创

关注

据推测，与钛相比，氧化锆可降低细菌的粘附性；然而，实验研究的结果颇具争议。本研究旨在体外使用三种生物膜和人类菌斑样本比较氧化锆和钛植入物表面上的生物膜形成。制备由钛（Ti）或氧化锆（ZrO 2）制成的实验盘，其具有机加工（M）或喷砂（SLA）和酸蚀刻（ZLA）表面形貌。体外使用三种生物膜或人菌斑样品用于细菌粘附到每种类型的原盘，孵育72小时后使用厌氧流动室模型评估。结果显示，与钛相比，氧化锆上三种

据推测，与钛相比，氧化锆可降低细菌的粘附性；然而，实验研究的结果颇具争议。本研究旨在体外使用三种生物膜和人类菌斑样本比较氧化锆和钛植入物表面上的生物膜形成。

制备由钛（Ti）或氧化锆（ZrO 2）制成的实验盘，其具有机加工（M）或喷砂（SLA）和酸蚀刻（ZLA）表面形貌。体外使用三种生物膜或人菌斑样品用于细菌粘附到每种类型的原盘，孵育72小时后使用厌氧流动室模型评估。

结果显示，与钛相比，氧化锆上三种生物膜厚度明显降低（ZrO2-M：8.41μm; ZrO2-ZLA：17.47μm; Ti-M：13.12μm; Ti-SLA：21.97μm）；然而，没有发现三种生物膜质量和代谢的差异。人菌斑分析显示ZrO2-M和ZrO2-ZLA的光密度值分别为0.06和0.08，Ti-M和Ti-SLA的光密度值分别为0.1和0.13；表明与钛相比，氧化锆上人体生物膜质量显著降低。此外，氧化锆显示人体斑块厚度在统计学上显著降低（ZrO2-M：9.04μm; ZrO2-ZLA：13.83μm; Ti-M：13.42μm; Ti-SLA：21.3μm），但与钛相比具有类似的人菌斑代谢。

综上所述，该研究结果表明，与钛植入物表面相比，在实验性厌氧流动室模型中孵育72小时后，氧化锆植入物表面人菌斑生物膜形成明显降低。

原始出处：

Roehling S, Astasov-Frauenhoffer M, et al., In Vitro Biofilm Formation on Titanium and Zirconia Implant Surfaces. J Periodontol. 2017 Mar;88(3):298-307. doi: 10.1902/jop.2016.160245. Epub 2016 Oct 7.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1727826, encodeId=80071e27826f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Oct 13 20:21:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679749, encodeId=fe0f16e974993, content=<a href='/topic/show?id=d4ac9639efa' target=_blank style='color:#2F92EE;'>#钛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96397, encryptionId=d4ac9639efa, topicName=钛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=927227807332, createdName=30397613, createdTime=Sat Oct 26 06:21:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459727, encodeId=f6441459e2768, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Fri Jan 04 10:21:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357007, encodeId=cf9f35e007e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jan 02 20:45:51 CST 2019, time=2019-01-02, status=1, ipAttribution=)]
    2019-10-13 一叶知秋

    #PE#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1727826, encodeId=80071e27826f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Oct 13 20:21:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679749, encodeId=fe0f16e974993, content=<a href='/topic/show?id=d4ac9639efa' target=_blank style='color:#2F92EE;'>#钛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96397, encryptionId=d4ac9639efa, topicName=钛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=927227807332, createdName=30397613, createdTime=Sat Oct 26 06:21:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459727, encodeId=f6441459e2768, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Fri Jan 04 10:21:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357007, encodeId=cf9f35e007e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jan 02 20:45:51 CST 2019, time=2019-01-02, status=1, ipAttribution=)]
    2019-10-26 30397613

    #钛#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1727826, encodeId=80071e27826f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Oct 13 20:21:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679749, encodeId=fe0f16e974993, content=<a href='/topic/show?id=d4ac9639efa' target=_blank style='color:#2F92EE;'>#钛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96397, encryptionId=d4ac9639efa, topicName=钛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=927227807332, createdName=30397613, createdTime=Sat Oct 26 06:21:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459727, encodeId=f6441459e2768, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Fri Jan 04 10:21:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357007, encodeId=cf9f35e007e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jan 02 20:45:51 CST 2019, time=2019-01-02, status=1, ipAttribution=)]
    2019-01-04 medsci248

    #氧化锆#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1727826, encodeId=80071e27826f8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Oct 13 20:21:00 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679749, encodeId=fe0f16e974993, content=<a href='/topic/show?id=d4ac9639efa' target=_blank style='color:#2F92EE;'>#钛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96397, encryptionId=d4ac9639efa, topicName=钛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=927227807332, createdName=30397613, createdTime=Sat Oct 26 06:21:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459727, encodeId=f6441459e2768, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Fri Jan 04 10:21:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357007, encodeId=cf9f35e007e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jan 02 20:45:51 CST 2019, time=2019-01-02, status=1, ipAttribution=)]
    2019-01-02 医者仁心5538

    学习了

    0